Skip to Content
Merck

An in vitro model of neuronal ensembles.

Nature communications (2022-06-11)
M Angeles Rabadan, Estanislao Daniel De La Cruz, Sneha B Rao, Yannan Chen, Cheng Gong, Gregg Crabtree, Bin Xu, Sander Markx, Joseph A Gogos, Rafael Yuste, Raju Tomer
ABSTRACT

Advances in 3D neuronal cultures, such as brain spheroids and organoids, are allowing unprecedented in vitro access to some of the molecular, cellular and developmental mechanisms underlying brain diseases. However, their efficacy in recapitulating brain network properties that encode brain function remains limited, thereby precluding development of effective in vitro models of complex brain disorders like schizophrenia. Here, we develop and characterize a Modular Neuronal Network (MoNNet) approach that recapitulates specific features of neuronal ensemble dynamics, segregated local-global network activities and a hierarchical modular organization. We utilized MoNNets for quantitative in vitro modelling of schizophrenia-related network dysfunctions caused by highly penetrant mutations in SETD1A and 22q11.2 risk loci. Furthermore, we demonstrate its utility for drug discovery by performing pharmacological rescue of alterations in neuronal ensembles stability and global network synchrony. MoNNets allow in vitro modelling of brain diseases for investigating the underlying neuronal network mechanisms and systematic drug discovery.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Nifedipine, ≥98% (HPLC), powder
Sigma-Aldrich
Picrotoxin, powder
Sigma-Aldrich
D(−)-2-Amino-5-phosphonopentanoic acid, NMDA receptor antagonist
Sigma-Aldrich
NBQX disodium salt hydrate, ≥98% (HPLC)
Sigma-Aldrich
Monoclonal Anti-phospho-Histone H3 (pSer28) antibody produced in rat, ~0.5 mg/mL, clone HTA28, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
trans-2-Phenylcyclopropylamine hydrochloride
Sigma-Aldrich
(+)-Bicuculline, ≥97.0% (TLC)
Sigma-Aldrich
Anti-NeuN Antibody, clone A60, clone A60, Chemicon®, from mouse